Charles Schwab Investment Management Inc. Buys 398,027 Shares of Agilon Health, Inc. $AGL

Key Points

• Charles Schwab Investment Management Inc. has increased its stake in Agilon Health, Inc. by 8.8%, resulting in ownership of 4,939,576 shares valued at approximately $21.39 million.
• Analysts have downgraded their price targets for Agilon Health, with estimates ranging from $1.00 to $5.00, and a consensus rating of "Hold" with a target price of $3.07.
• Agilon Health recently reported a quarterly loss of ($0.25) EPS, missing expectations and showing a revenue decline of 5.9% year-over-year.

Charles Schwab Investment Management Inc. increased its position in Agilon Health, Inc. (NYSE:AGL - Free Report) by 8.8% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 4,939,576 shares of the company's stock after acquiring an additional 398,027 shares during the quarter. Charles Schwab Investment Management Inc. owned about 1.20% of Agilon Health worth $21,388,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Humankind Investments LLC purchased a new stake in Agilon Health in the 4th quarter worth about $30,000. Raymond James Financial Inc. purchased a new stake in Agilon Health in the 4th quarter worth about $33,000. Cerity Partners LLC purchased a new stake in Agilon Health in the 4th quarter worth about $34,000. Nisa Investment Advisors LLC increased its holdings in Agilon Health by 244.9% in the 1st quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company's stock worth $41,000 after acquiring an additional 6,783 shares during the last quarter. Finally, Boothbay Fund Management LLC purchased a new stake in Agilon Health in the 4th quarter worth about $58,000.

Analyst Ratings Changes

Several equities research analysts recently weighed in on AGL shares. Benchmark decreased their price objective on Agilon Health from $4.00 to $1.50 and set a "buy" rating for the company in a report on Wednesday, August 6th. The Goldman Sachs Group lifted their target price on Agilon Health from $2.50 to $5.00 and gave the company a "neutral" rating in a report on Thursday, May 8th. Evercore ISI reduced their target price on Agilon Health from $5.00 to $3.00 and set an "in-line" rating for the company in a report on Wednesday, July 9th. Jefferies Financial Group reduced their target price on Agilon Health from $2.40 to $1.10 and set a "hold" rating for the company in a report on Friday, August 15th. Finally, Sanford C. Bernstein reaffirmed a "market perform" rating and set a $1.40 target price (down previously from $4.00) on shares of Agilon Health in a report on Wednesday, August 20th. Four investment analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $3.07.

Agilon Health Trading Up 6.1%

Shares of AGL traded up $0.08 during trading hours on Wednesday, reaching $1.31. 5,105,334 shares of the company's stock traded hands, compared to its average volume of 22,827,828. The stock has a market cap of $540.82 million, a PE ratio of -1.69 and a beta of 0.14. The firm's 50 day simple moving average is $1.81 and its 200-day simple moving average is $2.94. Agilon Health, Inc. has a 12 month low of $0.71 and a 12 month high of $6.08.

Agilon Health (NYSE:AGL - Get Free Report) last released its earnings results on Monday, August 4th. The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.14). The firm had revenue of $1.39 billion during the quarter, compared to the consensus estimate of $1.47 billion. Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%.The business's quarterly revenue was down 5.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.07) EPS. As a group, analysts expect that Agilon Health, Inc. will post -0.59 earnings per share for the current fiscal year.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.